SCHEMBL30108302

SCHEMBL30108302

COC(=O)C1CN(C(=O)OC)CCC12OCCO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.38
ALDH1A1 P00352 2/20 0.38
USP2 O75604 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
KMT2A Q03164 3/20 0.36
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 3/20 0.35
CHRNB2 P17787 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
MAPK1 P28482 2/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.34
CYP3A4 P08684 3/20 0.34
MEN1 O00255 1/20 0.34
PDK1 Q15118 1/20 0.34
HSD17B10 Q99714 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108295 0.78 CYP2C9 (0.35) POLBALDH1A1USP2CYP1A2CYP2C9
SCHEMBL30108294 0.78 CYP2D6 (0.38) POLBALDH1A1USP2CYP1A2CYP2C9
SCHEMBL18095946 0.77 EPHX1 (0.37) POLBALDH1A1USP2CYP1A2CYP2C9
SCHEMBL2081988 0.74 KMT2A (0.54) POLBALDH1A1USP2CYP1A2CYP2C9
SCHEMBL711832 0.71 ATM (0.34) CYP1A2CYP2C9CYP2C19LMNATSHR
SCHEMBL20303735 0.70 OPRK1 (0.32) LMNA
SCHEMBL9610 0.70 ATM (0.33) POLBALDH1A1CYP1A2CYP2C9CYP2D6
SCHEMBL15046910 0.68
SCHEMBL853368 0.68 CHRNB2 (0.35) CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL3622678 0.68 EPHX1 (0.40) ALDH1A1USP2CYP1A2CYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113549068-B Novel imidazopyridine compound, preparation method and medical application thereof 上海拓界生物医药科技有限公司 2022-12-02 CN disclosed